Insight Molecular Diagnostics Inc.
IMDX
$5.34
-$0.18-3.17%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -49.81% | -75.77% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -49.81% | -75.77% | |||
| Cost of Revenue | -27.98% | -79.16% | |||
| Gross Profit | -60.29% | -73.72% | |||
| SG&A Expenses | -4.29% | -4.95% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.95% | -5.25% | |||
| Operating Income | -8.98% | -20.58% | |||
| Income Before Tax | -11.41% | -46.04% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -11.41% | -46.04% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -11.41% | -46.04% | |||
| EBIT | -8.98% | -20.58% | |||
| EBITDA | -9.37% | -21.19% | |||
| EPS Basic | -11.37% | -17.18% | |||
| Normalized Basic EPS | -7.75% | 2.52% | |||
| EPS Diluted | -11.37% | -17.18% | |||
| Normalized Diluted EPS | -7.75% | 2.52% | |||
| Average Basic Shares Outstanding | 0.03% | 24.63% | |||
| Average Diluted Shares Outstanding | 0.03% | 24.63% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||